Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16,006 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of individual fitness score for conformity of prescriptions to the "Guidelines For Pharmacological Therapy of Schizophrenia".
Inada K, Fukumoto K, Hasegawa N, Yasuda Y, Yamada H, Hori H, Ichihashi K, Iida H, Ohi K, Muraoka H, Kodaka F, Ide K, Hashimoto N, Iga JI, Ogasawara K, Atake K, Takaesu Y, Nagasawa T, Komatsu H, Okada T, Furihata R, Kido M, Kikuchi S, Kubota C, Makinodan M, Ochi S, Takeshima M, Yamagata H, Matsumoto J, Miura K, Usami M, Kishimoto T, Onitsuka T, Katsumoto E, Hishimoto A, Numata S, Yasui-Furukori N, Watanabe K, Hashimoto R. Inada K, et al. Among authors: watanabe k. Neuropsychopharmacol Rep. 2022 Dec;42(4):502-509. doi: 10.1002/npr2.12293. Epub 2022 Oct 18. Neuropsychopharmacol Rep. 2022. PMID: 36254805 Free PMC article.
Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.
Takaesu Y, Watanabe K, Numata S, Iwata M, Kudo N, Oishi S, Takizawa T, Nemoto K, Yasuda Y, Tagata H, Tsuboi T, Tsujino N, Hashimoto N, Matsui Y, Hori H, Yamamori H, Sugiyama N, Suwa T, Kishimoto T, Hishimoto A, Usami M, Furihata R, Iwamoto K, Fujishiro H, Nakamura T, Mizuno K, Inagaki T, Katsumoto E, Tomita H, Ohi K, Muraoka H, Atake K, Iida H, Nagasawa T, Fujita J, Yamamura S, Onitsuka T, Murata A, Takayanagi Y, Noda H, Matsumura Y, Takezawa K, Iga JI, Ichihashi K, Ogasawara K, Yamada H, Inada K, Hashimoto R. Takaesu Y, et al. Among authors: watanabe k. Psychiatry Clin Neurosci. 2019 Oct;73(10):642-648. doi: 10.1111/pcn.12911. Epub 2019 Aug 22. Psychiatry Clin Neurosci. 2019. PMID: 31437336 Free PMC article.
Efficacy and safety of bright light therapy for manic and depressive symptoms in patients with bipolar disorder: A systematic review and meta-analysis.
Takeshima M, Utsumi T, Aoki Y, Wang Z, Suzuki M, Okajima I, Watanabe N, Watanabe K, Takaesu Y. Takeshima M, et al. Among authors: watanabe k, watanabe n. Psychiatry Clin Neurosci. 2020 Apr;74(4):247-256. doi: 10.1111/pcn.12976. Epub 2020 Feb 10. Psychiatry Clin Neurosci. 2020. PMID: 31917880 Free PMC article.
Pharmacological management of depression: Japanese expert consensus.
Sakurai H, Uchida H, Kato M, Suzuki T, Baba H, Watanabe K, Inada K, Kikuchi T, Katsuki A, Kishida I, Sugawara Kikuchi Y, Yasui-Furukori N; Medical Education Panel of the Japanese Society of Clinical Neuropsychopharmacology. Sakurai H, et al. Among authors: watanabe k. J Affect Disord. 2020 Apr 1;266:626-632. doi: 10.1016/j.jad.2020.01.149. Epub 2020 Jan 28. J Affect Disord. 2020. PMID: 32056937 Free article.
Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI).
Tsuboi T, Suzuki T, Azekawa T, Adachi N, Ueda H, Edagawa K, Katsumoto E, Kubota Y, Goto E, Hongo S, Watanabe Y, Kato M, Yasui-Furukori N, Yoshimura R, Nakagawa A, Kikuchi T, Watanabe K. Tsuboi T, et al. Among authors: watanabe y, watanabe k. Neuropsychiatr Dis Treat. 2020 Mar 31;16:881-890. doi: 10.2147/NDT.S246136. eCollection 2020. Neuropsychiatr Dis Treat. 2020. PMID: 32280229 Free PMC article.
Response to 'Efficacy and safety of bright light therapy for bipolar depression'.
Takeshima M, Utsumi T, Aoki Y, Wang Z, Suzuki M, Okajima I, Watanabe N, Watanabe K, Takaesu Y. Takeshima M, et al. Among authors: watanabe k, watanabe n. Psychiatry Clin Neurosci. 2020 Jul;74(7):410-411. doi: 10.1111/pcn.13010. Epub 2020 May 9. Psychiatry Clin Neurosci. 2020. PMID: 32388878 Free article. No abstract available.
Pharmacological management of bipolar disorder: Japanese expert consensus.
Sakurai H, Kato M, Yasui-Furukori N, Suzuki T, Baba H, Watanabe K, Inada K, Kishida I, Sugawara Kikuchi Y, Kikuchi T, Katsuki A, Uchida H; Medical Education Panel of the Japanese Society of Clinical Neuropsychopharmacology. Sakurai H, et al. Among authors: watanabe k. Bipolar Disord. 2020 Dec;22(8):822-830. doi: 10.1111/bdi.12959. Epub 2020 Jul 2. Bipolar Disord. 2020. PMID: 32558145 Free PMC article.
Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project.
Ichihashi K, Hori H, Hasegawa N, Yasuda Y, Yamamoto T, Tsuboi T, Iwamoto K, Kishimoto T, Horai T, Yamada H, Sugiyama N, Nakamura T, Tsujino N, Nemoto K, Oishi S, Usami M, Katsumoto E, Yamamori H, Tomita H, Suwa T, Furihata R, Inagaki T, Fujita J, Onitsuka T, Miura K, Matsumoto J, Ohi K, Matsui Y, Takaesu Y, Hashimoto N, Iga J, Ogasawara K, Yamada H, Watanabe K, Inada K, Hashimoto R. Ichihashi K, et al. Among authors: watanabe k. Neuropsychopharmacol Rep. 2020 Sep;40(3):281-286. doi: 10.1002/npr2.12122. Epub 2020 Jun 30. Neuropsychopharmacol Rep. 2020. PMID: 32602667 Free PMC article.
16,006 results
You have reached the last available page of results. Please see the User Guide for more information.